Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ganeden Biotech Signs Deal with Pathway International - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Ganeden Biotech Signs Deal with Pathway International

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Ganeden Biotech, Cleveland, OH, maker of the patented probiotic strain GanedenBC30, has partnered with Pathway International Pty Ltd., which will distribute GanedenBC30 in all Australian and New Zealand markets.

 
The partnership will provide growth opportunities for Ganeden Biotech through increased distribution channels and access to an exclusive international supply chain network of leading manufacturers in Australia and New Zealand.
 
“Partnering with Pathway International is an important step in achieving our global expansion goals for 2010,” said Andrew Lefkowitz, president and CEO, Ganeden Biotech. “We are confident that Pathway International’s proven track record in successfully distributing innovative health and wellness ingredients will help our probiotic reach consumers in these markets looking to improve their digestive health and boost immunity with probiotic-enhanced food, beverage and supplement products.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics